As medicine advances, many of the tasks that doctors performed nearly a century ago are now considered specializations. Radiology is one such medical specialty that has gained increasing recognition and understanding since the discovery of X-rays in 1895. While there are many people involved in this area of medicine, some have become exceptional in this industry. Salah Qanadli comes to mind when I talk about modern radiologists.
During his 20 years in medicine, Dr. Qanadli published in detail about radiology, cardiovascular diseases and most recently Covid-19 and vascular changes, as observed by chest computed tomography. CT is essentially a 3-D x-ray machine. He is currently chief physician at the Department of Radiodiagnostics and Interventional Radiology at the University Hospital Lausanne, Lausanne, Switzerland. Dr. Qanadli holds three patents. One invention that bears his name is the Qanadli score. It is a measuring instrument generated by computed tomography, with which the clot exposure in pulmonary embolism diseases can be quantified.
Dr. Qanadli was born in Rabat in 1964, received his medical training at the University of Paris VI in 1992 and obtained his PhD in biotechnology in 2001 from the Technical University of France. He was President of the Union of Swiss Societies for Vascular Medicine and President of the Swiss Society for Vascular and Interventional Radiology. In addition to his professional journey, he was granted active memberships in 10 national and international specialist societies.
The research of Dr. Qanadli, as an interventional radiologist, has also played a key role in studying the right treatment for various venous system disorders. He developed minimally invasive approaches to the treatment of obstruction of the superior vena cava, particularly those related to benign causes. He is characterized by his innovations in this area as techniques for repositioning the endovascular central catheter or as techniques for in-situ repair of the catheter function. Dr. Qanadli examined and presented a case treated by embolization under various conditions such as spontaneous spleen rupture, non-traumatic intramuscular hematoma, and pulmonary aneurysms. Another notable report he wrote was about acute aortic syndromes, in which he and his team members investigated better classification of aortic dissections to optimize patient management.
Dr. Qanadli has served the academic community for two decades, making him a highly respected figure in the medical world. The awards he has received, the research he has carried out, and the reports he has written indicate his expertise in the field of vascular disease.